TGS1
Basic information
Region (hg38): 8:55773446-55826445
Previous symbols: [ "NCOA6IP" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TGS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 41 | 54 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 41 | 5 | 11 |
Variants in TGS1
This is a list of pathogenic ClinVar variants found in the TGS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-55773649-G-C | not specified | Uncertain significance (May 09, 2023) | ||
8-55773673-C-G | not specified | Uncertain significance (Dec 17, 2023) | ||
8-55773677-A-T | not specified | Uncertain significance (Oct 05, 2021) | ||
8-55782760-G-T | not specified | Uncertain significance (Jan 31, 2022) | ||
8-55782801-G-A | not specified | Likely benign (Jan 23, 2024) | ||
8-55782806-A-T | not specified | Uncertain significance (May 13, 2024) | ||
8-55785748-G-C | not specified | Uncertain significance (Sep 07, 2022) | ||
8-55785806-G-A | Benign (Jul 02, 2018) | |||
8-55785834-G-A | not specified | Uncertain significance (May 14, 2024) | ||
8-55785874-G-C | not specified | Uncertain significance (Dec 28, 2022) | ||
8-55785875-C-A | not specified | Uncertain significance (Mar 25, 2024) | ||
8-55785877-C-T | not specified | Uncertain significance (Sep 27, 2022) | ||
8-55786265-A-G | Benign (Feb 26, 2018) | |||
8-55786314-A-C | not specified | Uncertain significance (Nov 08, 2022) | ||
8-55786346-G-A | Benign/Likely benign (Nov 01, 2022) | |||
8-55786376-A-G | Benign (May 18, 2018) | |||
8-55786454-A-C | not specified | Uncertain significance (Apr 25, 2023) | ||
8-55786506-A-G | not specified | Uncertain significance (Dec 16, 2023) | ||
8-55786547-A-G | not specified | Uncertain significance (Oct 20, 2023) | ||
8-55786554-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
8-55786564-A-C | Likely benign (Dec 01, 2022) | |||
8-55786566-T-G | not specified | Uncertain significance (May 13, 2022) | ||
8-55786667-G-T | not specified | Uncertain significance (Nov 29, 2023) | ||
8-55786673-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
8-55786683-T-C | not specified | Uncertain significance (Apr 23, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TGS1 | protein_coding | protein_coding | ENST00000260129 | 13 | 52307 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.10e-12 | 0.902 | 125667 | 0 | 81 | 125748 | 0.000322 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.16 | 503 | 435 | 1.16 | 0.0000207 | 5682 |
Missense in Polyphen | 147 | 136.76 | 1.0749 | 1748 | ||
Synonymous | -0.285 | 158 | 154 | 1.03 | 0.00000780 | 1496 |
Loss of Function | 2.01 | 25 | 38.4 | 0.650 | 0.00000169 | 531 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000758 | 0.000757 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000331 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000274 | 0.000273 |
Middle Eastern | 0.000331 | 0.000326 |
South Asian | 0.000503 | 0.000490 |
Other | 0.000658 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the 2 serial methylation steps for the conversion of the 7-monomethylguanosine (m(7)G) caps of snRNAs and snoRNAs to a 2,2,7-trimethylguanosine (m(2,2,7)G) cap structure. The enzyme is specific for guanine, and N7 methylation must precede N2 methylation. Hypermethylation of the m7G cap of U snRNAs leads to their concentration in nuclear foci, their colocalization with coilin and the formation of canonical Cajal bodies (CBs). Plays a role in transcriptional regulation. {ECO:0000269|PubMed:11517327, ECO:0000269|PubMed:11912212, ECO:0000269|PubMed:16687569, ECO:0000269|PubMed:18775984}.;
- Pathway
- RNA transport - Homo sapiens (human);Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);Metabolism of lipids;snRNP Assembly;Metabolism of RNA;Metabolism;Phosphatidylinositol phosphate metabolism;Metabolism of non-coding RNA
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.885
- rvis_EVS
- 2.61
- rvis_percentile_EVS
- 98.77
Haploinsufficiency Scores
- pHI
- 0.287
- hipred
- Y
- hipred_score
- 0.537
- ghis
- 0.465
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.518
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tgs1
- Phenotype
- growth/size/body region phenotype; cellular phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- spliceosomal snRNP assembly;7-methylguanosine RNA capping;regulation of lipid metabolic process;ribonucleoprotein complex biogenesis;7-methylguanosine cap hypermethylation
- Cellular component
- extracellular space;nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;Cajal body;small nuclear ribonucleoprotein complex
- Molecular function
- protein binding;RNA methyltransferase activity;RNA trimethylguanosine synthase activity